OTCMKTS:MDCL Medicine Man Technologies (MDCL) Stock Price, News & Analysis → Democrats Push to Replace Dollar With Digital Coin, Control Currency. (From Monetary Gold) (Ad) Free MDCL Stock Alerts $0.51 +0.06 (+13.33%) (As of 05/15/2024 ET) Add Compare Share Share Today's Range$0.43▼$0.5850-Day Range$0.45▼$1.1252-Week Range$1.05▼$4.05Volume343,898 shsAverage Volume84,948 shsMarket CapitalizationN/AP/E RatioN/ADividend YieldN/APrice TargetN/A Stock AnalysisStock AnalysisChartFinancialsSEC FilingsStock AnalysisChartFinancialsSEC Filings Get Medicine Man Technologies alerts: Email Address Ad Monetary GoldTrump Reveals Conspiracy Behind Fed-Controlled Digital Currency.Donald Trump once again sounded the alarm against Fed-controlled digital currencies (CBDCs). If these plans are implemented, it could mean the end of America as we know it.This means you must act NOW before it's too late. About Medicine Man Technologies Stock (OTCMKTS:MDCL)Medicine Man Technologies, Inc. provides advisory and consulting services related to cannabis cultivation. It offers consulting, application and licensing, cultivation technology, dispensary operations, facility design and training services. The firm products include Nutrients, The Big Tomato and Three A Light. The company was founded by Andrew Williams on March 20, 2014 and is headquartered in Denver, CO.Read More MDCL Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart MDCL Stock News HeadlinesMay 11, 2024 | americanbankingnews.comMedicine Man Technologies (OTCMKTS:MDCL) Share Price Passes Below 50-Day Moving Average of $0.82March 28, 2024 | finance.yahoo.comQ4 2023 Medicine Man Technologies Inc Earnings CallFebruary 27, 2024 | msn.comExplore world of medicine at STEAMCONFebruary 14, 2024 | wsj.comMedicine Man Technologies Inc.November 20, 2023 | msn.com13 Action News Big Story: Advancing MedicineOctober 2, 2023 | msn.comLexington native Dr. Drew Weissman who won Nobel Prize in medicine tells reporters he first thought it was a ‘prank’September 4, 2023 | cnn.comYour AI doctor will see you now: How technology is disrupting medicine and beyond in South AfricaMay 11, 2023 | markets.businessinsider.comMedicine Man Technologies earnings preview: what Wall Street is expectingApril 1, 2023 | benzinga.comBenchmark Reiterates Buy on Medicine Man Technologies, Maintains $3 Price TargetFebruary 25, 2023 | marketwatch.comHomeopathic Medicine Market Size In 2023 : Emerging Technologies, Opportunity and Forecast to 2028February 25, 2023 | msn.comNo Man’s Sky: Fractal Update Is Available TodayFebruary 17, 2023 | usatoday.comHow mindfulness and technology can break through mental health barriersFebruary 9, 2023 | msn.comCosmetic workers accused of practicing medicine without a licenseSeptember 13, 2022 | msn.comCentre releases NLEM, includes 384 drugs across 27 therapeutic categories, adds 34 new medicines to listSeptember 7, 2022 | yahoo.comMichigan Medicine Modernizes Digital Experience for Healthcare Consumers in Expansion with LoyalAugust 24, 2022 | finance.yahoo.comThe Dr. Johan Blickman Scholarship Gives Back To Next Generation of Medical DoctorsAugust 21, 2022 | msn.comThe future of pediatric medicine: Chemical castration and surgical mutilationAugust 20, 2022 | msn.comMind Medicine surges 78% after report reveals activist stake of college student who made $110 million in Bed Bath & Beyond rallyAugust 2, 2022 | msn.comNavy veteran, aspiring doctor identified as man who drowned saving rafters along American RiverJuly 1, 2022 | msn.comNational Doctors' Day 2022: How to become a Doctor by following these 4 stepsJune 28, 2022 | finance.yahoo.comUNIVERSITY OF MARYLAND MEDICINE LAUNCHES PRECISION HEALTH STUDY TO CREATE BIGGEST AND MOST DIVERSE RESEARCH DATABASE IN STATEJune 21, 2022 | msn.comMDC Inducts 138 Qualified DoctorsSee More Headlines Receive MDCL Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Medicine Man Technologies and its competitors with MarketBeat's FREE daily newsletter. Email Address Industry, Sector and Symbol Stock ExchangeOTCMKTS SectorIndustrials Industry Business Services Sub-IndustryCannabis Current SymbolOTCMKTS:MDCL Previous SymbolNASDAQ:MDCL CUSIPN/A CIK1622879 Webmedicinemantechnologies.com Phone(303) 371-0387FaxN/AEmployees25Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet IncomeN/A Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on AssetsN/A Debt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/A Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book ValueN/A Price / BookN/AMiscellaneous Outstanding SharesN/AFree FloatN/AMarket CapN/A OptionableNot Optionable BetaN/A 7 Stocks to Own Before the 2024 ElectionLooking to avoid the hassle of mudslinging, volatility, and uncertainty? You'd need to be out of the market, which isn’t viable. So where should investors put their money? Find out with this report.Get This Free Report Key ExecutivesJustin DyeExecutive Chairman & Chief Executive OfficerNancy Bush HuberChief Financial OfficerNirup KrishnamurthyChief Integration & Information OfficerLee Alexander DaytonChief Administrative OfficerMarc HarvillManager-Business DevelopmentKey CompetitorsAffinion GroupOTCMKTS:AFGRIngenico Group - GCSOTCMKTS:INGIF2020 BulkersOTC:TTBKF3 Sixty Risk SolutionsOTCMKTS:PTVYF8i Enterprises AcquisitionOTCMKTS:JFKKUView All Competitors MDCL Stock Analysis - Frequently Asked Questions How have MDCL shares performed in 2024? Medicine Man Technologies' stock was trading at $0.6097 on January 1st, 2024. Since then, MDCL stock has decreased by 16.4% and is now trading at $0.51. View the best growth stocks for 2024 here. What other stocks do shareholders of Medicine Man Technologies own? Based on aggregate information from My MarketBeat watchlists, some companies that other Medicine Man Technologies investors own include Curaleaf (CURLF), Charlotte's Web (CWBHF), Trulieve Cannabis (TCNNF), KushCo (KSHB), Organigram (OGI), Green Thumb Industries (GTBIF), Innovative Industrial Properties (IIPR) and CV Sciences (CVSI). How do I buy shares of Medicine Man Technologies? Shares of MDCL stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. This page (OTCMKTS:MDCL) was last updated on 5/16/2024 by MarketBeat.com Staff From Our PartnersThe #1 Biotech Stock to Watch in 2024 is Attacking Viruses in a Unique WaySmallcaps DailyWATCH: The Truth About InflationBirch GoldRed Alert: Your Money's Disappearance Act - Banks' Greed Unleashed!Priority GoldHealthcare Takes A Big Step Forward With The Help Of AIThe Bull ReportDemocrats Push to Replace Dollar With Digital Coin, Control Currency.Monetary GoldTop 5 AI Stocks to Buy for 2024Market Moving TrendsTrump’s “Tax Free” Retirement Strategy Gold Safe ExchangeDoes this make you sick?Allegiance Gold Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Medicine Man Technologies, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.